Business Context and Reporting Period
This Form 8-K is filed by ADVENTRX Pharmaceuticals, Inc. (not Savara Inc.) on March 20, 2009. The filing addresses the company's financial results for the three-month and full-year periods ended December 31, 2008, and announces a material restatement of previously issued financial statements.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being contained in a press release (Exhibit 99.1) issued on March 25, 2009, which is not included in the provided text.
Material Changes and Restatement
- Non-Reliance Notice: Management concluded that consolidated financial statements in the 2007 Form 10-K and 2007-2008 Form 10-Qs should no longer be relied upon.
- Cause of Error: Misstatements resulted from the erroneous retrospective application of FSP EITF 00-19-2 regarding the accounting for warrant liability for the years ended December 31, 2005, and 2006.
- Impact Assessment: The error affected only non-cash line items. It had no impact on current assets (cash, cash equivalents, short-term investments), operating expenses, loan covenants, or other contractual requirements.
- Correction Plan: The company intends to correct these misstatements in its annual report on Form 10-K for the year ended December 31, 2008, anticipated to be filed before March 31, 2009.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance or management commentary on future operations. The primary risk disclosed is the historical inaccuracy of financial statements due to accounting errors, which has been communicated to the Audit Committee and the independent registered public accounting firm, J.H. Cohn LLP.
Investor Verification Checklist
- Verify the corrected financial figures in the upcoming Form 10-K for the year ended December 31, 2008.
- Review the press release (Exhibit 99.1) for specific revenue and expense data for 2008.
- Confirm that the warrant liability adjustment remains a non-cash item with no impact on liquidity or debt covenants.
- Monitor the filing timeline to ensure the corrected 10-K is submitted by the anticipated March 31, 2009 deadline.